References

  1. References
  2. Azizi, M., Saxena, M., Wang, Y., Jenkins, J. S., Devireddy, C., Rader, F., Fisher, N. D. L., Schmieder, R. E., Mahfoud, F., Lindsey, J., Sanghvi, K., Todoran, T. M., Pacella, J., Flack, J., Daemen, J., Sharp, A. S. P., Lurz, P., Bloch, M. J., Weber, M. A., … RADIANCE II Investigators and Collaborators. (2023). Endovascular ultrasound renal denervation to treat hypertension: The RADIANCE II randomized clinical trial. JAMA, 329(8), 651-661. https://doi.org/10.1001/jama.2023.0713
  3. Bisognano, J. D., Bakris, G., Nadim, M. K., Sanchez, L., Kroon, A. A., Schafer, J., de Leeuw, P. W., & Sica, D. A. (2011). Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: Results from the double-blind, randomized, placebo-controlled Rheos pivotal trial. Journal of the American College of Cardiology, 58(7), 765-773. https://doi.org/10.1016/j.jacc.2011.06.008
  4. Böhm, M., Kario, K., Kandzari, D. E., Mahfoud, F., Weber, M. A., Schmieder, R. E., Tsioufis, K., Pocock, S., Konstantinidis, D., Choi, J. W., East, C., Lee, D. P., Ma, A., Ewen, S., Cohen, D. L., Wilensky, R., Devireddy, C. M., Lea, J., Schmid, A., … SPYRAL HTN-OFF MED Pivotal Investigators. (2020). Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): A multicentre, randomised, sham-controlled trial. The Lancet, 395(10234), 1444-1451. https://doi.org/10.1016/s0140-6736(20)30554-7
  5. Corral-Acero, J., Margara, F., Marciniak, M., Rodero, C., Loncaric, F., Feng, Y., Gilbert, A., Fernandes, J. F., Bukhari, H. A., Wajdan, A., Martinez, M. V., Santos, M. S., Shamohammdi, M., Luo, H., Westphal, P., Leeson, P., DiAchille, P., Gurev, V., Mayr, M., … Lamata, P. (2020). The ‘Digital Twin’ to enable the vision of precision cardiology. European Heart Journal, 41(48), 4556-4564. https://doi.org/10.1093/eurheartj/ehaa159
  6. European Parliament & Council of the European Union. (2024). Regulation (EU) 2024/1689 of 13 June 2024 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act). Official Journal of the European Union. https://eur-lex.europa.eu/eli/reg/2024/1689/oj
  7. Ienca, M., & Andorno, R. (2017). Towards new human rights in the age of neuroscience and neurotechnology. Life Sciences, Society and Policy, 13(1), 5. https://doi.org/10.1186/s40504-017-0050-1
  8. Koizumi, A., Amano, K., Cortese, A., Shibata, K., Yoshida, W., Seymour, B., Kawato, M., & Lau, H. (2017). Fear reduction without fear through reinforcement of neural activity that bypasses conscious exposure. Nature Human Behaviour, 1, 0006. https://doi.org/10.1038/s41562-016-0006
  9. McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., Hanssen, H., Harris, J., Lauder, L., McManus, R. J., Molloy, G. J., Rahimi, K., Regitz-Zagrosek, V., Rossi, G. P., Sandset, E. C., … Khamidullaeva, G. A. (2024). 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal, 45(38), 3912-4018. https://doi.org/10.1093/eurheartj/ehae178
  10. Musk, E., & Neuralink. (2019). An integrated brain-machine interface platform with thousands of channels. Journal of Medical Internet Research, 21(10), e16194. https://doi.org/10.2196/16194
  11. Nolan, R. P., Floras, J. S., Harvey, P. J., Kamath, M. V., Picton, P. E., Chessex, C., Hiscock, N., Powell, J., Catt, M., Hendrickx, H., Talbot, D., & Chen, M. H. (2010). Behavioral neurocardiac training in hypertension: A randomized, controlled trial. Hypertension, 55(4), 1033-1039. https://doi.org/10.1161/hypertensionaha.109.146233
  12. Shibata, K., Watanabe, T., Sasaki, Y., & Kawato, M. (2011). Perceptual learning incepted by decoded fMRI neurofeedback without stimulus presentation. Science, 334(6061), 1413-1415. https://doi.org/10.1126/science.1212003
  13. Silvani, A., Calandra-Buonaura, G., Dampney, R. A., & Cortelli, P. (2016). Brain-heart interactions: Physiology and clinical implications. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 374(2067), 20150181. https://doi.org/10.1098/rsta.2015.0181
  14. Stavrakis, S., Stoner, J. A., Humphrey, M. B., Morris, L., Filiberti, A., Reynolds, J. C., Elkholey, K., Javed, I., Twidale, N., Riha, P., Varahan, S., Scherlag, B. J., Jackman, W. M., Dasari, T. W., & Po, S. S. (2020). TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): A randomized clinical trial. JACC: Clinical Electrophysiology, 6(3), 282-291. https://doi.org/10.1016/j.jacep.2019.11.008
  15. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. (1996). Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation, 93(5), 1043–1065. https://doi.org/10.1161/01.CIR.93.5.1043
  16. Thayer, J. F., & Lane, R. D. (2009). Claude Bernard and the heart-brain connection: Further elaboration of a model of neurovisceral integration. Neuroscience & Biobehavioral Reviews, 33(2), 81-88. https://doi.org/10.1016/j.neubiorev.2008.08.004
  17. U.S. Food and Drug Administration. (2025). Marketing submission recommendations for a predetermined change control plan for artificial intelligence-enabled device software functions: Guidance for industry and Food and Drug Administration staff. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial-intelligence
  18. Vasey, B., Nagendran, M., Campbell, B., Clifton, D. A., Collins, G. S., Denaxas, S., Denniston, A. K., Faes, L., Geerts, B., Ibrahim, M., Liu, X., Mateen, B. A., Mathur, P., McCradden, M. D., Morgan, L., Ordish, J., Rogers, C., Saria, S., Ting, D. S. W., … DECIDE-AI expert group. (2022). Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. Nature Medicine, 28(5), 924-933. https://doi.org/10.1038/s41591-022-01772-9
  19. World Health Organization. (2021). Ethics and governance of artificial intelligence for health: WHO guidance. https://www.who.int/publications/i/item/9789240029200